Menopause
Guidelines
New guideline offers recommendations for reproductive health in patients with rheumatic diseases
Among its many recommendations, the guideline strongly advises that women with RMD considering pregnancy switch to pregnancy‐compatible medication...
From the Editor
Progestin-only systemic hormone therapy for menopausal hot flashes
Clinicians treating postmenopausal hot flashes often recommend “systemic estrogen treatment.” However, progestin-only therapy also can effectively...
Conference Coverage
Menopause hormone therapy found to delay type 2 diabetes
LOS ANGELES – Transdermal delivery of estrogen is the preferred means of administration in women who are obese, who have a risk of DVT, or who...
Conference Coverage
Early postmenopausal risk management leads to ‘optimum health’ for women
PHILADELPHIA – “There’s a major opportunity for us at the onset of menopause to identify risks and initiate preventive strategies.”
Latest News
Bisphosphonates turn 50
ORLANDO – The progress seen in treating postmenopausal women with breast cancer, is not evident in younger, premenopasual women or for other...
Expert Commentary
Does BSO status affect health outcomes for women taking estrogen for menopause?
What do results from the Women’s Health Initiative’s 18-year follow-up study reveal?
Product Review
Product Update: Addyi alcohol ban lifted, fezolinetant trial, outcomes tracker, comfort gown
FDA Removes Alcohol Ban with Addyi
Sprout Pharmaceuticals announced that the US Food and Drug Administration (FDA) has removed...
Conference Coverage
Ovarian cryopreservation should no longer be experimental
PHILADELPHIA – Most patients who underwent ovarian tissue freezing followed by reimplantation went on to have successful spontaneous pregnancies...
News for Your Practice
What does the REPLENISH trial reveal about E2/P4’s ability to affect VMS and sleep and appropriate dosing for smokers?
Compared with placebo, women taking E2/P4 experienced reduced VMS frequency and severity and improved sleep
The REPLENISH...
News for Your Practice
Postmenopausal women would benefit from clinician-initiated discussion of GSM symptoms
Almost 20% of postmenopausal women wished that their practitioner had addressed their vulvovaginal health in a discussion at...
Expert Commentary
Can we discern optimal long-term osteoporosis treatment for women?
The use of osteoporosis drugs in sequence—rather than a single agent for a long time—may be the most effective management...